Max van Noesel

Full Professor

Strategic program(s):

Strategic program(s):

Contact

Recent publications

A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma Atia Samim, Gitta Bleeker, Kathelijne C.J.M. Kraal, Max M. van Noesel, Bart de Keizer, Godelieve A.M. Tytgat
EJC Paediatric Oncology, 2024, vol. 3
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy Judith Wienke, Lindy L Visser, Waleed M Kholosy, Kaylee M Keller, Marta Barisa, Evon Poon, Sophie Munnings-Tomes, Courtney Himsworth, Elizabeth Calton, Ana Rodriguez, Ronald Bernardi, Femke van den Ham, Sander R van Hooff, Yvette A H Matser, Michelle L Tas, Karin P S Langenberg, Philip Lijnzaad, Anne L Borst, Elisa Zappa, Francisca J Bergsma, Josephine G M Strijker, Bronte M Verhoeven, Shenglin Mei, Amira Kramdi, Restuadi Restuadi, Alvaro Sanchez-Bernabeu, Annelisa M Cornel, Frank C P Holstege, Juliet C Gray, Godelieve A M Tytgat, Marijn A Scheijde-Vermeulen, Marc H W A Wijnen, Miranda P Dierselhuis, Karin Straathof, Sam Behjati, Wei Wu, Albert J R Heck, Jan Koster, Stefan Nierkens, Isabelle Janoueix-Lerosey, Ronald R de Krijger, Ninib Baryawno, Louis Chesler, John Anderson, Hubert N Caron, Thanasis Margaritis, Max M van Noesel, Jan J Molenaar
Cancer Cell, 2024, vol. 42, p.283-300.e8
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma Nathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter, Ahmad Javadi, Ruben van Paemel, Charlotte Vandeputte, Katleen De Preter, Bram De Wilde, Mathieu Chicard, Yasmine Iddir, Gudrun Schleiermacher, Olivia Ruhen, Janet Shipley, Marta Fiocco, Johannes H M Merks, Max M van Noesel, C Ellen van der Schoot, Godelieve A M Tytgat, Janine Stutterheim
JCO Precision Oncology, 2023, vol. 7
Outcome of patients with undifferentiated embryonal sarcoma of the liver treated according to European soft tissue sarcoma protocols Florent Guérin, Hélène Martelli, Timothy Rogers, Ilaria Zanetti, Sheila Terwisscha van Scheltinga, Federica De Corti, Gabriella Guillen Burrieza, Véronique Minard-Colin, Daniel Orbach, Max M. van Noesel, Marie Karanian, Raquel Dávila Fajardo, Johannes H.M. Merks, Andrea Ferrari, Gianni Bisogno
Pediatric Blood and Cancer, 2023, vol. 70, p.1-8
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma Thomas F Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K Alles, Marli E Ebus, Rana Dandis, Harm van Tinteren, Huib N Caron, Jan Koster, Max M van Noesel, Godelieve A M Tytgat, Selma Eising, Rogier Versteeg, M Emmy M Dolman, Jan J Molenaar
Frontiers in oncology, 2023, vol. 13, p.1-10
Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm Jette J. Bakhuizen, Saskia M.J. Hopman, Machteld I. Bosscha, Charlotte J. Dommering, Marry M. van den Heuvel-Eibrink, Janna A. Hol, Lennart A. Kester, Marco J. Koudijs, Karin P.S. Langenberg, Jan L.C. Loeffen, Jasper van der Lugt, Annette C. Moll, Max M. van Noesel, Stephanie E. Smetsers, Evelien de Vos-Kerkhof, Johannes H.M. Merks, Roland P. Kuiper, Marjolijn C.J. Jongmans
JAMA network open, 2023, vol. 6, p.1-8